PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CVS vs. VYM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CVS and VYM is 0.56, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

CVS vs. VYM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in CVS Health Corporation (CVS) and Vanguard High Dividend Yield ETF (VYM). The values are adjusted to include any dividend payments, if applicable.

100.00%150.00%200.00%250.00%300.00%350.00%NovemberDecember2025FebruaryMarchApril
213.14%
309.86%
CVS
VYM

Key characteristics

Sharpe Ratio

CVS:

-0.27

VYM:

0.04

Sortino Ratio

CVS:

-0.11

VYM:

0.14

Omega Ratio

CVS:

0.98

VYM:

1.02

Calmar Ratio

CVS:

-0.19

VYM:

0.04

Martin Ratio

CVS:

-0.52

VYM:

0.23

Ulcer Index

CVS:

20.56%

VYM:

2.49%

Daily Std Dev

CVS:

40.46%

VYM:

13.63%

Max Drawdown

CVS:

-64.07%

VYM:

-56.98%

Current Drawdown

CVS:

-36.37%

VYM:

-12.78%

Returns By Period

In the year-to-date period, CVS achieves a 43.62% return, which is significantly higher than VYM's -7.67% return. Over the past 10 years, CVS has underperformed VYM with an annualized return of -2.01%, while VYM has yielded a comparatively higher 8.89% annualized return.


CVS

YTD

43.62%

1M

-3.47%

6M

0.93%

1Y

-9.93%

5Y*

6.00%

10Y*

-2.01%

VYM

YTD

-7.67%

1M

-9.92%

6M

-7.75%

1Y

1.56%

5Y*

14.70%

10Y*

8.89%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CVS vs. VYM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CVS
The Risk-Adjusted Performance Rank of CVS is 4141
Overall Rank
The Sharpe Ratio Rank of CVS is 4040
Sharpe Ratio Rank
The Sortino Ratio Rank of CVS is 3838
Sortino Ratio Rank
The Omega Ratio Rank of CVS is 3737
Omega Ratio Rank
The Calmar Ratio Rank of CVS is 4444
Calmar Ratio Rank
The Martin Ratio Rank of CVS is 4545
Martin Ratio Rank

VYM
The Risk-Adjusted Performance Rank of VYM is 2929
Overall Rank
The Sharpe Ratio Rank of VYM is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of VYM is 2727
Sortino Ratio Rank
The Omega Ratio Rank of VYM is 2828
Omega Ratio Rank
The Calmar Ratio Rank of VYM is 3030
Calmar Ratio Rank
The Martin Ratio Rank of VYM is 3030
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CVS vs. VYM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for CVS Health Corporation (CVS) and Vanguard High Dividend Yield ETF (VYM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CVS, currently valued at -0.27, compared to the broader market-2.00-1.000.001.002.00
CVS: -0.27
VYM: 0.04
The chart of Sortino ratio for CVS, currently valued at -0.11, compared to the broader market-6.00-4.00-2.000.002.004.00
CVS: -0.11
VYM: 0.14
The chart of Omega ratio for CVS, currently valued at 0.98, compared to the broader market0.501.001.502.00
CVS: 0.98
VYM: 1.02
The chart of Calmar ratio for CVS, currently valued at -0.19, compared to the broader market0.001.002.003.004.00
CVS: -0.19
VYM: 0.04
The chart of Martin ratio for CVS, currently valued at -0.52, compared to the broader market-10.000.0010.0020.00
CVS: -0.52
VYM: 0.23

The current CVS Sharpe Ratio is -0.27, which is lower than the VYM Sharpe Ratio of 0.04. The chart below compares the historical Sharpe Ratios of CVS and VYM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.27
0.04
CVS
VYM

Dividends

CVS vs. VYM - Dividend Comparison

CVS's dividend yield for the trailing twelve months is around 4.18%, more than VYM's 3.15% yield.


TTM20242023202220212020201920182017201620152014
CVS
CVS Health Corporation
4.18%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%1.14%
VYM
Vanguard High Dividend Yield ETF
3.15%2.74%3.12%3.01%2.76%3.18%3.03%3.40%2.80%2.91%3.22%2.78%

Drawdowns

CVS vs. VYM - Drawdown Comparison

The maximum CVS drawdown since its inception was -64.07%, which is greater than VYM's maximum drawdown of -56.98%. Use the drawdown chart below to compare losses from any high point for CVS and VYM. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-36.37%
-12.78%
CVS
VYM

Volatility

CVS vs. VYM - Volatility Comparison

CVS Health Corporation (CVS) and Vanguard High Dividend Yield ETF (VYM) have volatilities of 7.91% and 8.10%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%NovemberDecember2025FebruaryMarchApril
7.91%
8.10%
CVS
VYM
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab